EHA 2023 | The importance of a multidisciplinary approach to treat amyloidosis
Efstathios Kastritis
• 10 Jun 2023
Efstathios Kastritis, MD, University of Athens School of Medicine, Athens, Greece, explains why a multidisciplinary team (MDT) approach is essential for the effective treatment of amyloidosis, sharing his recommendations for how to best manage complications during treatment. This interview took place at the 28th Congress of the European Hematology Association (EHA) 2023 in Frankfurt, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
GSK: Honoraria; Takeda: Honoraria; Pfizer: Honoraria, Research Funding; Genesis Pharma: Honoraria; Janssen: Honoraria, Research Funding; Amgen: Honoraria, Research Funding.
